KBI Biopharma Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:KBI Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014010
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products. The organization’s service portfolio includes process development and cGMP manufacturing of recombinant protein active pharmaceutical ingredients, protein characterization, formulation, process design and development and testing. KBI also offers technology transfer, modeling and simulation and release testing and stability programs. The organization caters to clients worldwide to accelerate and optimize their drug development programs. It has offices in Durham, Boulder and The Woodlands. KBI is headquartered in Durham, North Carolina, the US.

KBI Biopharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KBI Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
KBI Biopharma To Acquire Biologics Operations Of Merck 10
Venture Financing 11
GlycoSeLect Raises USD0.5 Million in Seed Round of Financing 11
Aeglea BioTherapeutics Raises Additional USD1 Million in Series A Venture Financing 12
Acquisition 13
KBI Biopharma to Acquire Alliance Protein Labs 13
JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma 14
KBI Biopharma Inc – Key Competitors 15
KBI Biopharma Inc – Key Employees 16
KBI Biopharma Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
May 23, 2017: JSR Life Sciences Expands Manufacturing Capabilities at KBI Biopharma 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KBI Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KBI Biopharma Inc, Deals By Therapy Area, 2011 to YTD 2017 8
KBI Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
KBI Biopharma To Acquire Biologics Operations Of Merck 10
GlycoSeLect Raises USD0.5 Million in Seed Round of Financing 11
Aeglea BioTherapeutics Raises Additional USD1 Million in Series A Venture Financing 12
KBI Biopharma to Acquire Alliance Protein Labs 13
JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma 14
KBI Biopharma Inc, Key Competitors 15
KBI Biopharma Inc, Key Employees 16
KBI Biopharma Inc, Other Locations 17

★海外企業調査レポート[KBI Biopharma Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emirates Flight Catering:企業の戦略・SWOT・財務分析
    Emirates Flight Catering - Strategy, SWOT and Corporate Finance Report Summary Emirates Flight Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Savior Lifetec Corp (4167):製薬・医療:M&Aディール及び事業提携情報
    Summary Savior Lifetec Corp (SLC) is an injectable manufacturer and distributor. The company offers active pharmaceutical ingredients (APIs) and finished dosage formulations. It provides sterile crystallization and aseptic processing of sterile powder. SLC offers carbapenem products, which include i …
  • Advocate Health Care-製薬・医療分野:企業M&A・提携分析
    Summary Advocate Health Care (Advocate Health) is a nonprofit health system that provides health care services. It provides health care services such as inpatient acute and non-acute care, primary and specialty physician services and various outpatient services to communities in Illinois. The organi …
  • Knight-Swift Transportation Holdings Inc (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Wienerberger AG:企業のM&A・事業提携・投資動向
    Wienerberger AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wienerberger AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Amerinac Holding Corp.:企業の戦略・SWOT・財務情報
    Amerinac Holding Corp. - Strategy, SWOT and Corporate Finance Report Summary Amerinac Holding Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hamilton Thorne Ltd (HTL):企業の財務・戦略的SWOT分析
    Summary Hamilton Thorne Ltd (Hamilton Thorne) is a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm …
  • Enbridge Inc (ENB)-エネルギー分野:企業M&A・提携分析
    Summary Enbridge Inc. (Enbridge) is an integrated energy company. It carries out natural gas gathering, processing, transmission and distribution; transportation of crude oil; and marketing of petroleum products. The company also involved in power generation and transmission and has interests in ren …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Plains All American Pipeline LP (PAA):企業の財務・戦略的SWOT分析
    Plains All American Pipeline LP (PAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • JGC Holdings Corp (1963):企業の財務・戦略的SWOT分析
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Topdanmark AS (TOP):企業の財務・戦略的SWOT分析
    Topdanmark AS (TOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cardinal Health, Inc.:企業の戦略・SWOT・財務分析
    Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Millennium Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Millennium Pharmaceuticals Inc (Millennium), a subsidiary of Takeda Pharmaceutical Company Ltd is a biopharmaceutical company that undertakes research, development, and commercialization of drugs for treating cancer. The company’s product Velcade is used for the treatment of multiple myeloma …
  • University of Dundee-製薬・医療分野:企業M&A・提携分析
    Summary University of Dundee (Dundee) is an educational research university that offers a range of undergraduate, postgraduate, postgraduate research degree, distant learning and English language programs. The university offers a wide range of academic and research courses in various disciplines suc …
  • NV Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary NV Energy, Inc. (NVE), an indirect subsidiary of Berkshire Hathaway Energy Company, is an energy company, which provides a wide range of energy services and products through its principal subsidiaries, Nevada Power Company and Sierra Pacific Power Company. It delivers electricity to a large …
  • Integra LifeSciences Holdings Corporation:企業の戦略・SWOT・財務情報
    Integra LifeSciences Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Integra LifeSciences Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mitobridge Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mitobridge Inc (Mitobridge), formerly Mitokyne, Inc. is a drug development company that discovers and develops small molecule therapeutics. The company offers products that enhance the mitochondrial functions. It develops therapies for rare diseases and then expand into more common diseases. …
  • Bharti Infratel Ltd:企業の戦略・SWOT・財務情報
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆